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Abstract The p53 tumor suppressor that plays a central role in
the cellular response to genotoxic stress was suggested to be
associated with the DNA repair machinery which mostly involves
nucleotide excision repair (NER). In the present study we show
for the first time that p53 is also directly involved in base excision
repair (BER). These experiments were performed with p53
temperature-sensitive (ts) mutants that were previously studied in
in vivo experimental models. We report here that p53 ts mutants
can also acquire wild-type activity under in vitro conditions.
Using ts mutants of murine and human origin, it was observed
that cell extracts overexpressing p53 exhibited an augmented
BER activity measured in an in vitro assay. Depletion of p53
from the nuclear extracts abolished this enhanced activity.
Together, this suggests that p53 is involved in more than one
DNA repair pathway.
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1. Introduction
The p53 tumor suppressor gene plays a central role in the
cellular response to genotoxic stress [1^5]. Activated wild-type
p53 may lead to the onset of apoptosis [4,6^11] or alterna-
tively turn on the DNA repair machinery [2^5,12] leading to
the completion of the cell cycle.
It is well accepted that p53 is essential for the maintenance
of the normal genome integrity and stability [1^3,13^15]. Data
accumulated from several laboratories have suggested that
p53 plays a role in mediating the response to DNA damage,
by orchestrating both G1 growth arrest and induction of
apoptosis. Levels of p53 rapidly increase upon DNA damage,
mainly through the stabilization of the p53 protein [1^4,15].
In general, it is believed that induction of p53-dependent cell
growth arrest [16,17] is expected to permit DNA repair. How-
ever, when damage is irreparable and the DNA repair machi-
nery fails, the multi-step apoptotic process is induced [18^20].
The involvement of wild-type p53 in DNA repair has pre-
viously been suggested. Indeed, p53 was shown to speci¢cally
transactivate the GADD-45 gene [21]. Furthermore, p53 was
found to form complexes with proliferating cell nuclear anti-
gen (PCNA) or with replication protein A (RPA) which are
directly involved in DNA replication and repair [21^23]. p53
was also shown to form a complex with XPB (ERCC3) and
RPA [24,25], both part of the multifactor complex involved in
nucleotide excision repair. p53 was suggested to modulate the
nucleotide excision repair (NER) pathway [12,26^30], where it
was shown to be associated with DNA excision repair medi-
ated by polymerase N or O [31]. Recently, it was found that the
C-terminus of wild-type p53 may directly bind single-stranded
DNA that catalyzes renaturation and annealing of comple-
mentary DNA strands [32]. Wild-type p53 protein, but not
mutant p53, exhibits 3P-to-5P exonuclease activity [33^35].
The DNA repair-related activity of p53 was shown to be
controlled by the C-terminus. This part of the molecule was
shown to bind XPB, an analog of the yeast RAD3, and XPD,
constituents of transcription factor IIH (TFIIH) and CSB, the
strand-speci¢c DNA repair enzyme [30], to interact with the
human Rad51 [36,37], RPA [21] and ERCC3 [30,38]. The C-
terminal domain of the human p53 molecule binds non-spe-
ci¢c single-stranded [27,39,40] and mismatched DNA [28].
This domain of the murine regularly spliced p53 form
(p53RS) also contains a DNA helicase activity [28,29,39,41],
characteristic of many DNA repair proteins.
DNA repair is a complex process involving several path-
ways designed to address the various types of damaged DNA
encountered by cells following both external and internal sig-
nals [42]. Base excision repair (BER) and NER are two major
DNA repair mechanisms [42^45]. NER is involved mainly in
the removal of the major UV-induced photoproducts caused
by sunlight and other bulky DNA lesions [42^44]. BER acts
continuously on both spontaneous and induced DNA damage
caused by hydrolysis, oxygen free radicals, and simple alkylat-
ing agents [45,46]. BER is initiated by the hydrolysis of the N-
glycosylic bond linking a modi¢ed base to the deoxyribose,
which excises the base residue in the free form. As a result of
glycosylase activity, apurinic or apyrimidinic (AP) sites are
generated. The removal of AP sites is initiated by a second
class of BER enzymes, the apurinic/apyrimidinic endonu-
cleases. AP endonucleases produce incisions at the AP sites
which are further excised by DNA deoxyribophosphodiester-
ase. The resulting single nucleotide gap is ¢lled by repair syn-
thesis and DNA repair is completed by DNA ligase [42,45].
The association of p53 with the DNA repair machinery was
mostly observed in model systems in which the NER path-
ways were measured [12,21,22,23,26^30]. To further elucidate
the molecular mechanism which underlies the involvement of
p53 in DNA repair, we focused our research on evaluating the
activity of the p53 protein in the BER pathway. The observa-
tion that this is a predominant pathway essential for the main-
tenance of DNA integrity makes BER an attractive model for
getting further insight into the possible role of p53 in DNA
repair. In our study, we took advantage of our novel obser-
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vation that temperature-sensitive (ts) mutant p53 proteins of
murine and human origin from cells grown at the non-per-
missive temperature gained wild-type activity when shifted to
the permissive temperature in vitro. We found that nuclear
extracts containing active p53 exhibited higher DNA repair
synthesis compared to those without p53. Furthermore, ex-
haustion of p53 by anti-p53 monoclonal antibodies abolished
the p53-dependent DNA repair synthesis. Interestingly, at the
non-permissive temperature, extracts containing mutant p53
consistently exhibited lower DNA repair synthesis than p53
null nuclear cell extracts.
2. Materials and methods
2.1. Construction of DNA molecules containing AP sites
The plasmids pSP65 (3 kb) and pSP65-8-3 (4.5 kb) were puri¢ed
using the Qiagen kit and further puri¢ed on a CsCl gradient. Depu-
rination of pSP65 was carried out by heating 11 Wg DNA in 40 Wl
bu¡er containing 0.01 M sodium citrate and 0.1 M KCl (pH 5.0) at
70‡C for 45’. The depurinated DNA was neutralized by the addition
of 10 Wl of 0.2 M Tris-HCl (pH 7.8). pSP65 served as the AP+
plasmid which contains the AP sites while pSP65-8-3, AP3, served
as control.
2.2. DNA repair assay
Cell line M1/2, a p53 non-producer myeloid cell line and derived
clones expressing the murine p53 135val ts mutant [47], established
previously were used in our experiments [48] as well as novel clones
expressing the human 143 ValCAla, also known as temperature-sen-
sitive mutations [49], were used. The M1/2 clones expressing the hu-
man ts143 p53 mutant were generated by infecting the M1/2 parental
cells with p53 retroviral stocks obtained from 293GP packaging cell
line [50], transfected with the corresponding cDNA construct. Nuclear
extracts were prepared by a modi¢ed protocol according to that de-
scribed before [51]. Brie£y, 106^107 cells were washed twice with cold
PBS, cell pellets were resuspended in 400 Wl bu¡er A (10 mM HEPES-
KOH pH 7.9; 1.5 mM MgCl2 ; 10 mM KCl; 0.5 mM DTT; 0.2 mM
PMSF; 10 W/ml leupeptin; 1 Wg/ml pepstatin and 10 Wg/ml aprotinin)
by gentle pipetting. After 15’ incubation on ice, 25 Wl of 10% NP-40
was added and vortexing was performed vigorously for 10’. After
centrifugation, cell pellets were resuspended in 150^300 Wl of bu¡er
C (20 mM HEPES-KOH pH 7.9; 25% glycerol; 420 mM NaCl; 1.5
mM MgCl2 ; 0.2 mM EDTA; 0.5 mM DTT; 0.2 mM PMSF; 10 Wg/
ml leupeptin; 1 Wg/ml pepstatin and 10 Wg/ml aprotinin). Tubes were
transferred to a rotating platform for 15’ at 4‡C. After centrifugation
the supernatant was kept at 370‡C.
Extracts were analyzed for protein concentration (Bradford assay).
The DNA repair assay was carried out in 25 Wl containing 40 mM
Tris pH 7.6, 12 mM MgCl2, 1 mM DTT, 0.1 mM dTTP, dATP,
dCTP, 0.01 mM dGTP, 3% PEG, 0.3 Wg depurinated pSP65 plasmid
(treated for 45’, as described above), 0.3 Wg untreated plasmid, 0.25 Wl
[K-32P]dGTP, 30 mM KCl, and 0.5^1.5 Wg of nuclear extracts.
Samples were incubated at 37‡C or 32‡C for 15’. 5 Wl of stop bu¡er
(120 mM EDTA, 1.2% SDS) was added to each sample and incubated
for 10’ at 60‡C. 20 Wg of proteinase K was added and incubated at
37‡C for 1 h. Then 170 Wl TE was added, phenol/chloroform extracted
and ethanol precipitated. DNA was linearized with BamHI and frac-
tionated through a 0.7% agarose gel in TBE. Gels were UV photo-
graphed, dried and analyzed by phosphorimaging. Speci¢c DNA re-
pair synthesis was calculated by dividing net counts in the
phosphorimager (taken as PSL3background:AP3 in each individual
lane) by the DNA content assessed by UV incorporation. The ¢nal
numbers of DNA repair synthesis (%) are the ratio of an average of
duplicates in each sample as a percentage of that in M1/2 cell extract
used in each experiment. Standard deviation was calculated in all
experiments.
2.3. DNA mobility shift assay
The DNA mobility shift mobility assay was performed as previ-
ously described [52]. Brie£y, 10^20 fmol of radiolabeled DNA was
mixed with 5 Wg of nuclear extract. 1 Wl of PAb-421 ascitic £uid,
2 Wg (2 Wl) of poly dI-dC and 10 Wl of bu¡er (25 mM Tris-HCl,
100 mM KCl, 6.25 mM MgCl2, 0.5 mM EDTA, 1 mM DTT and
10% glycerol) were added. The reactions were incubated for 30’ at
32‡C or 37‡C, loaded on a 4% polyacrylamide gel and electro-
phoresed.
2.4. Monoclonal antibodies
Anti-p53 monoclonal antibodies PAb-421 [53] and PAb-419 anti-
LTAg of SV40, used as a negative control, were obtained either from
supernatants of growing hybridoma cell lines or from ascitic £uids of
hybridoma-bearing syngeneic mice.
2.5. p53 protein analysis by FACS
Cells were washed in PBS and ¢xed for 1.5 h at 4‡C in 70% meth-
anol at a concentration of 0.5^2U106 cells/ml. Fixed cells were incu-
bated for 30’ on ice with 1 Wg of anti-p53 monoclonal antibody PAb-
421. Cells were washed twice with PBS containing 0.5% w/v BSA
(fraction V) and 0.02% w/v sodium azide (PBA solution), and incu-
bated for 30’ on ice with a second donkey anti-mouse or rabbit anti-
mouse IgG (H+L chains) FITC-conjugated antibody (Jackson
Immunoresearch) diluted 1:50 in 50 Wl PBA solution per sample.
2.6. Depletion of p53 protein
Two Wg of nuclear cell extracts was mixed with 5 Wl of 50% Sephar-
ose-protein A conjugated with anti-p53 monoclonal antibodies (PAb-
421) or non-conjugated beads or no beads at all, in total volume of
20 Wl in bu¡er C (see Section 2.2). Mixtures were incubated at 4‡C for
1 h on a rocking tray. Finally, mixtures were centrifuged and DNA
repair synthesis was determined in supernatants.
3. Results
3.1. Augmentation of BER activity by p53 at the permissive
temperature
The in vitro DNA repair assay that we adopted [54,55]
consisted of two di¡erent sized plasmids: AP+ (3 kb), con-
taining AP sites, and AP3 (4.5 kb), lacking AP sites, incu-
bated together with a nuclear cell extract and radioactively
labeled nucleotide ([K-32P]dGTP). Upon completion of the
reaction, the two plasmids were linearized, separated through
an agarose gel and the levels of radioactivity, re£ecting DNA
repair synthesis, were measured by phosphorimaging.
In order to demonstrate the involvement of p53 in DNA
repair, it was critical to obtain p53 protein in the active wild-
type conformation and at su⁄cient levels to demonstrate spe-
ci¢c activity in an in vitro DNA repair assay. The fact that
wild-type p53 is a cell cycle control protein, expressed at very
low levels in normal cells, makes it di⁄cult to use nuclear
extracts obtained from normal growing cells as a suitable
source for that purpose. On the other hand, overexpression
of wild-type p53 leads to massive cell death via apoptosis. For
that reason, we studied DNA repair activity in cell lines ex-
pressing the well characterized p53val135 ts mutant [47]. At
the permissive temperature (32‡C) these cells express the ac-
tive p53 form, whereas cells grown at the non-permissive tem-
perature (37‡C) express the mutant p53 form.
It was previously shown that various ts proteins may gain
an active conformation following shift to permissive temper-
ature under in vitro conditions [56^60]. In order to examine
whether this is the case for p53, we measured the DNA repair
synthesis of nuclear extracts obtained from cells grown at
37‡C, but maintained in vitro for the DNA repair reaction
at 32‡C, to permit the acquisition of the active form. Fig. 1
demonstrates that the DNA repair synthesis mediated by
p53ts61, a p53 producer cell line generated by infection of
the parental M1/2 cell line with the retroviral vector contain-
ing the p53val135 ts inducible mutant [48], was signi¢cantly
enhanced. Fig. 1A depicts the actual amount of DNA used in
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each reaction, while Fig. 1B represents the radioactive signal
incorporated into the individual plasmids. Fig. 1C illustrates
the relative DNA repair synthesis estimated as the ratio of
radioactivity detected in the individual samples and that of
M1/2 nuclear cell extract. The basal activity observed in the
M1/2 cell extract was signi¢cantly enhanced by p53 (compare
M1/2 with p53ts61 in Fig. 1C). A twofold increase in the
DNA repair synthesis was consistently observed, thus suggest-
ing that this increment is a result of p53 expression.
The model system that we were utilizing consists of highly
proliferating cells. It was therefore essential to con¢rm that
uptake of radioactive nucleotides is attributed to DNA repair
synthesis rather than to DNA replication. The observation
that activity was detected mainly with the AP+ plasmid and
not with the AP3 plasmid strongly suggests that the meas-
ured increment is attributed solely to DNA repair. It should
be added that our experiments were performed at the range
where repair synthesis correlated linearly with the number of
AP sites (data not shown). This was further substantiated by
the fact that the reactions were performed in the absence of
ATP or any other energy source essential for DNA replica-
tion. Furthermore, we found that addition of ddNTPs, which
blocks BER via inhibition of DNA polymerase L, reduced the
speci¢c radioactive incorporation (Fig. 1), while N-ethylmalei-
mide (NEM) (an inhibitor of all polymerases except L) [42,61]
barely a¡ected incorporation (see Fig. 1). In addition, incor-
poration was observed with radiolabeled dGTP but not with
dCTP, typical for very short patch repair AP sites, generated
under the experimental conditions, via BER (data not shown).
This suggests that we are indeed measuring the BER pathway
in this assay.
3.2. Kinetics of p53-dependent and -independent BER activity
To further establish the conclusion that enhanced DNA
repair synthesis is a direct result of wild-type p53 activity
gained under in vitro conditions, we compared the kinetics
of DNA repair synthesis with nuclear cell extracts of M1/2
and p53ts61 cells grown at 37‡C but maintained in vitro at
either the permissive temperature (32‡C) or the non-permis-
sive temperature (37‡C). As seen in Fig. 2A, a signi¢cant
increase in DNA repair synthesis was observed only at
32‡C. At 37‡C, the kinetics of the DNA repair synthesis medi-
ated by nuclear cell extracts of p53ts61 expressing mutant p53
was signi¢cantly lower than that induced by M1/2 (Fig. 2B).
The observation that mutant p53 did not induce any DNA
repair synthesis, but rather consistently seemed to reduce it,
suggests that mutant p53 may act by a negative transdomi-
nant mechanism. It should be noted that BER activity pro-
moted by extracts from M1/2 was higher at 37‡C than at
32‡C. The above results support the conclusion that although
the cells were grown at 37‡C, where they express the mutant
conformation, when nuclear cell extracts are maintained at
32‡C in vitro, p53 acquires the wild-type activity.
3.3. Acquisition of wild-type p53 DNA binding activity
To con¢rm the observation that the p53val135 ts mutant
acquires its wild-type activity under in vitro conditions, we
measured its speci¢c DNA binding activity, a hallmark of
the wild-type p53 protein [52,62,63]. Nuclear cell extracts ob-
tained from cells grown at 37‡C were mixed with radioactively
labeled DNA oligonucleotide consisting of p53 responsive el-
ement at either 37‡C or 32‡C, in the presence or absence of
anti-p53 monoclonal antibody PAb-421, and subjected to
electromobility shift assay. As can be seen in Fig. 2C, a spe-
ci¢c band shift with p53ts61 was observed only at 32‡C. No
band was evident at the non-permissive temperature (37‡C).
As expected, nuclear extracts of PLXSN, a cell line generated
by infection of the parental M1/2 cell line with the empty
retroviral vector, did not exhibit any speci¢c supershifted
band at either temperature. Recombinant wild-type p53 ex-
hibited similar band shift patterns at both temperatures.
Judged by these observations, we conclude that induction of
wild-type p53 activity mediated by the p53val135 ts mutant
may occur at the permissive temperature (32‡C) in an in vitro
cell-free system.
3.4. BER activity mediated by various p53 producer clones
To establish the correlation between p53 expression and
DNA repair synthesis, p53val135 ts clones expressing variable
levels of the p53 protein were compared. M1/2 and PLXSN
represent p53 null controls, whereas clones p53ts74, p53ts75,
p53ts53, p53ts64, p53ts61, and p53ts63 express increasing lev-
els of p53 [48]. p53 protein levels, estimated by FACS analy-
sis, using the PAb-421 anti-p53 monoclonal antibody, are
presented in Fig. 3B. DNA repair synthesis induced by nu-
Fig. 1. p53 stimulates DNA base excision repair. Duplicate samples
of linearized AP+ and AP3 plasmids of the various reactions were
separated by gel electrophoresis and exposed to UV (A) or analyzed
for radioactivity by phosphorimaging (B). Repair synthesis (%) is
calculated as described in Section 2 (C). Non-treated extracts (3),
dideoxy-NTPs (ddNTP) and N-ethylmaleimide (NEM).
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clear extracts obtained from the various p53 producer clones
was compared. As can be seen in Fig. 3A, cell lines exhibiting
various levels of p53 showed corresponding DNA repair syn-
thesis. Again, p53-dependent DNA repair synthesis was re-
stricted to 32‡C.
3.5. BER activity mediated by the human p53 ts mutant
In the above experiments we used the well characterized
murine p53 ts mutant. In order to exclude the possibility
that our ¢ndings are restricted to the murine cDNA clone,
we examined the activity of a human p53 ts mutant in our
assay. To that end, we generated M1/2 p53 producer clones
which express various levels of human p53 ts protein encoded
by the p53val143 ts cDNA. We selected for our experiments
two representative clones which express di¡erent levels of the
human p53 protein. As shown in Fig. 4A, clone p53ts103
expresses lower levels of p53 protein than clone p53ts106.
PLXSN is a parental derived clone generated by infection
with the empty retrovirus. Nuclear extracts obtained from
these clones were subjected to the DNA repair assay in vitro
at the permissive temperature. As shown in Fig. 4B, repair
synthesis mediated by cell extracts obtained from the human
Fig. 2. Comparison between DNA repair synthesis mediated by p53 ts mutant at the permissive and the non-permissive temperatures. Time
course of the relative DNA repair synthesis (%) at 32‡C (A) and 37‡C (B). Each point represents a duplicate; p53ts61 (F) and M1/2 clone (a)
cell extracts. DNA binding activity of p53 at both temperatures (C). DNA mobility band shift analysis of recombinant wild-type p53 protein
(Bac-H47), nuclear cell extracts of p53 non-producer PLXSN and p53ts61 cell extracts in the presence (+) or the absence (3) of PAb-421 at ei-
ther 32‡C or 37‡C.
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ts producer cells exhibited a signi¢cantly higher repair syn-
thesis. Furthermore, clone p53ts106 seems to exhibit higher
DNA repair synthesis than that induced by nuclear extracts
derived from the p53ts103 clone. These results suggest that
our methodology of using an in vitro system for the acquis-
ition of wild-type conformation to p53 ts mutant is not unique
to the murine-derived ts clones, but rather represents a more
general trend. Furthermore, BER activity seems to correlate
with p53 protein levels. It should be noted that fold induction
in DNA repair was consistently higher with the human p53 ts
mutant than that observed above with the mouse one.
3.6. Reduction in BER activity following p53 depletion
To further correlate p53 and DNA repair we depleted the
nuclear extracts of their p53 content and measured whether
this would obliterate the p53-dependent DNA repair. The
various nuclear cell extracts were treated with anti-p53 mono-
clonal antibodies and the speci¢c complexes were conjugated
onto Sepharose-protein A beads. Fig. 5 shows that the en-
hanced DNA repair synthesis of p53ts61 was signi¢cantly re-
duced following depletion of the p53 protein (see Fig. 5C:
p53ts61+PAb-421). This reduction was not observed when
either Sepharose-protein A (p53ts61+protein A) or a control
of anti-large T antigen antibody was added (p53ts61+PAb-
419). As expected, no signi¢cant e¡ect was noted when M1/
2 cells were treated similarly. Our attempts to restore DNA
repair activity to the depleted extracts by adding recombinant
p53 were not successful. This may be due to the fact that the
recombinant p53 protein may not be correctly processed to
mediate such an activity.
4. Discussion
Genomic stability is central for the maintenance of the nor-
mal life of the cell. Wild-type p53 plays a key physiological
role in these pathways [1^3,13^15]. External and internal
stress signals were shown to activate the p53 that may induce
DNA repair leading to the completion of the cell cycle, or
alternatively, apoptosis and cell di¡erentiation leading to
exit from the cell cycle. Although several models have been
proposed for the function of the activated p53, it is still un-
clear what determines the onset of the speci¢c p53-dependent
pathway in a given cell. Most of the reports are focused on
the analysis of the role of p53 in apoptosis. However, less has
been reported on the nature of its involvement in DNA repair.
This might be due to the fact that in most in vivo inducible
p53 experimental models, onset of p53 expression leads to an
immediate apoptotic response which could have overridden
the possible induction and/or detection of the DNA repair
pathways. Such a scenario is supported by a recent study
showing that cellular stress response to UV irradiation de-
pends on UV dose. p53-dependent repair occurs following
exposure to low UV doses while apoptosis follows exposure
to high doses of UV [64]. It is possible that in all p53 inducible
experimental systems p53 protein levels produced are compa-
rable to amounts that already induce apoptosis and thus do
not permit the detection of DNA repair, which requires mod-
erate levels of the protein.
Several molecular mechanisms by which p53 functions in
apoptosis have been described (for a review see [65]). Acti-
vated wild-type p53 was shown to directly transactivate apop-
tosis-related genes by interaction with the p53 responsive se-
quences found in promoter genes such the Bax gene, a positive
apoptosis-related gene [66]. The CD95/Fas/Apo1, a member
of the cell surface death-induced receptor family, is directly
induced by wild-type p53 expression [67,68]. In this case, a
p53 responsive element was found in the ¢rst intron of the
CD95 gene [69]. Recently, it was suggested that the p53-CD95
association may be controlled by yet another mechanism,
where p53 was suggested to stimulate the tra⁄cking of the
CD95/Fas death receptor from the Golgi system to the cell
surface [70]. Another interesting mode of interaction of wild-
type p53 with members of apoptosis-related genes consists of
a direct protein-protein interaction. For example, the cas-
pases, a family of cysteine aspartate proteases whose function
is central to the apoptotic process, were found to complex
with wild-type p53 protein [71].
Much less is known about the molecular mechanism that
underlies the nature of wild-type p53 involvement in the DNA
repair machinery. Several studies indicated that the involve-
ment of p53 in NER is associated with protein complex for-
Fig. 3. DNA repair synthesis mediated by nuclear extracts obtained
from cell lines expressing various levels of p53 protein. Graphic rep-
resentation of the relative DNA repair synthesis (%) (A). Evaluation
of p53 expression in the various p53 ts clones (M1/2:1; PLXSN:2;
p53ts74:3; p53ts75:4; p53ts53:5; p53ts64:6; p53ts61:7; p53ts63:8)
by FACS analysis; counts (number of cells) versus the level of £uo-
rescent FITC (p53 expression)(B).
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mation through its C-terminus with XPD, XPB and CSB,
NER-speci¢c proteins [22,24,30,72]. Li-Fraumeni-derived ¢-
broblasts homozygous for p53 were found to be de¢cient in
the removal of UV-induced dimers but still pro¢cient in the
transcription-coupled repair pathway [24]. Recently, it was
found that expression of p53 resulted in the recovery of nor-
mal levels of cyclobutane pyrimidine dimers and 6-4 photo-
product in genomic DNA alters the transcription-coupled re-
pair of the cyclobutane pyrimidine dimers, thus further
supporting the conclusion that wild-type p53 is central to
NER activity in human ¢broblasts [12].
As in apoptosis, wild-type p53 was also suggested to trans-
inactivate DNA repair-associated genes such as GADD-45
[21]. Furthermore, expression of the DNA repair protein
O6-methylguanine-DNA methyltransferase induced by ioniz-
ing irradiation was shown to be directly facilitated by tran-
scriptional activation mediated by wild-type p53 protein [73].
Another link between p53 and DNA repair is manifested by
the fact that wild-type p53 was found to be directly phos-
phorylated by the ATM kinase [74^76], a gene product of
the ATM gene that is defective in patients with ataxia telan-
giectasia, a syndrome characterized by pleiotropic phenotypes
including extreme sensitivity to ionizing irradiation.
p53 ts mutants were extensively used in in vivo cellular
models. In all these studies it clearly appeared that temper-
ature shifting of cells armed the p53 molecule with the protein
conformation to induce wild-type p53-dependent cell growth
arrest and apoptosis [6,47,49]. Our present data show that
acquisition of wild-type activity of both murine and human
ts p53 may also occur under in vitro conditions following
temperature shift. The p53 ts mutants enhanced DNA repair
synthesis as well as speci¢c DNA binding following mainte-
nance in vitro of nuclear extracts at the permissive temper-
ature. Gain of wild-type conformation in vitro was also ob-
served with other ts proteins such as VPg-pU and VPg-pUpU
of enterovirus 70, which formed only at 33‡C but not at 39‡C
[59]; ts mutant of SV40 large T-antigen, which replicates
DNA only at 39‡C [58] ; a ts pol2 DNA repair enzyme of
Saccharomyces cerevisiae [60] and the L-subunit of DNA
polymerase III [56], which are active only at the permissive
temperature.
Using an in vitro experimental system we found that ex-
pression of p53 protein with a wild-type conformation in-
duced BER activity in a cell-free system. It is most likely
that under in vitro conditions, using cell extracts, the apop-
totic pathways are shut o¡ and thus the involvement of p53 in
DNA repair can be seen. Interestingly, the mutant p53 protein
not only did not induce BER activity but rather seemed to
reduce the p53-independent BER activity measured in our
assay. This mutant-associated activity may indicate a negative
‘gain of function’ resembling our previous observations where
mutant p53 exerted a blocking activity in p53-independent
apoptotic pathways [48,77].
The plasticity of the p53 molecule has repeatedly been sug-
gested. Wild-type p53 protein may exhibit several conforma-
tions. Through allosteric activation, p53 may turn from a
‘latent’ form to an ‘activated’ form, not necessarily following
Fig. 5. Reduction in the p53-dependent DNA repair synthesis fol-
lowing treatment with anti-p53 antibodies. Nuclear cell extracts of
the M1/2 and p53ts61 cell lines were treated with anti-p53 mono-
clonal antibodies and the immunocomplexes were removed by ab-
sorption onto Sepharose-protein A beads (PAb-421). Controls of
cell extracts treated with Sepharose-protein A only (protein A) or a
non-relevant antibody anti-large T antigen (PAb-419). Non-treated
extracts (3). A, B, C see legend to Fig. 1.
Fig. 4. DNA repair synthesis mediated by nuclear extracts obtained from cell lines expressing the human p53 ts mutant at the permissive tem-
perature. Western blot analysis of PLXSN, p53 non-producer, and p53ts103; p53ts106, human-derived p53 producer clones (A). Graphic repre-
sentation of the relative DNA repair synthesis (%) mediated by the di¡erent p53 ts human expressing clones (B).
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re-folding of ‘denatured’ p53 [78]. Likewise, a ‘tensed’ state of
p53 with low a⁄nity to DNA has been suggested to turn into
a ‘relaxed’ form with high a⁄nity to DNA [79]. The temper-
ature sensitivity for conformation was suggested to be an in-
trinsic property of wild-type p53 [57].
In conclusion, our present experiments indicate for the ¢rst
time that p53 is directly involved in base excision repair.
Under in vitro conditions, murine and human ts p53 mutant
proteins were found to gain wild-type activity which acceler-
ates base excision repair following shift to the permissive tem-
perature. This suggests that p53 is central to the DNA repair
machinery and is involved in both the NER- and the BER-
speci¢c pathways.
Acknowledgements: This work was supported in part by grants from
the Israel-USA Binational Science Foundation (BSF) and the German
Israeli Foundation for Scienti¢c Research and Development (GIF)
(V.R.) and the Israel Cancer Research Fund (to V.R. and Z.L.).
V.R. is the incumbent of the Norman and Helen Asher Professorial
Chair in Cancer Research at the Weizmann Institute. Z.L. is the
incumbent of the Maxwell Ellis Professorial Chair in Biomedical Re-
search.
References
[1] Lane, D.P. (1992) Nature 358, 15^16.
[2] Kastan, M.B., Onyekwere, O., Sidransky, D., Vogelstein, B. and
Craig, R.W. (1991) Cancer Res. 51, 6304^6311.
[3] Kuerbitz, S.J., Plunkett, B.S., Walsh, W.V. and Kastan, M.B.
(1992) Proc. Natl. Acad. Sci. USA 89, 7491^7495.
[4] Lu, X. and Lane, D.P. (1993) Cell 75, 765^778.
[5] Nelson, W.G. and Kastan, M.B. (1994) Mol. Cell. Biol. 14, 1815^
1823.
[6] Yonish-Rouach, E., Resnitzky, K., Lotem, J., Sachs, L., Kimchi,
A. and Oren, M. (1991) Nature 352, 345^347.
[7] Lowe, S.W., Schmitt, E.M., Smith, S.W., Osborne, B.A. and
Jacks, T. (1993) Nature 362, 847^853.
[8] Symonds, H., Krall, L., Remington, L., Saenz-Robles, M., Lowe,
S., Jacks, T. and Van Dyke, T. (1994) Cell 78, 703^711.
[9] Clarke, A.R., Purdie, C.A., Harrison, D.J., Morris, R.G., Bird,
C.C., Hooper, M.L. and Wyllie, A.H. (1993) Nature 362, 849^
852.
[10] Clarke, A.R., Gledhill, S., Hooper, L.M., Bird, C.C. and Wyllie,
H.A. (1994) Oncogene 9, 1767^1773.
[11] Strasser, A., Harris, A.W., Jacks, T. and Cory, S. (1994) Cell 79,
329^339.
[12] Ford, J.M. and Hanawalt, P.C. (1997) J. Biol. Chem. 272, 28073^
28080.
[13] Maltzman, W. and Czyzyk, L. (1984) Mol. Cell. Biol. 4, 1689^
1694.
[14] Kastan, M.B. et al. (1992) Cell 71, 587^597.
[15] Livingstone, L.R., White, A., Sprouse, J., Livanos, E., Jacks, T.
and Tlsty, T.D. (1992) Cell 70, 923^935.
[16] Yonish-Rouach, E., Grunwald, D., Wilder, S., Kimchi, A., May,
E., Lawrence, J.J., May, P. and Oren, M. (1993) Mol. Cell. Biol.
13, 1415^1423.
[17] Oren, M. (1994) Semin. Cancer Biol. 5, 221^227.
[18] Wyllie, A.H. (1995) Curr. Opin. Genet. Dev. 5, 97^104.
[19] Williams, G.T. (1991) Cell 65, 1097^1098.
[20] Oltvai, Z.N. and Korsmeyer, S.J. (1994) Cell 79, 189^192.
[21] Dutta, A., Ruppert, J.M., Aster, J.C. and Wincherester, E. (1993)
Nature 365, 79^82.
[22] Smith, M.L. et al. (1994) Science 266, 1376^1378.
[23] Miller, S.D., Moses, K., Jayaraman, L. and Prives, C. (1997)
Mol. Cell. Biol. 17, 2194^2201.
[24] Ford, J.M. and Hanawalt, P.C. (1995) Proc. Natl. Acad. Sci.
USA 92, 8876^8890.
[25] Wang, X.W., Forrester, K., Yeh, H., Feitelson, M.A., Gu, J. and
Harris, C. (1994) Proc. Natl. Acad. Sci. USA 91, 2230^2234.
[26] Wu, L., Bayle, H., Elenbaas, B., Pavletich, N.P. and Levine, A.J.
(1995) Mol. Cell. Biol. 15, 497^504.
[27] Jayaraman, L. and Prives, C. (1995) Cell 81, 1021^1029.
[28] Lee, S., Elenbaas, B., Levine, A. and Gri⁄th, J. (1995) Cell 81,
1013^1020.
[29] Reed, M., Woelker, B., Wang, P., Wang, Y., Anderson, M.E.
and Tegtmeyer, P. (1995) Proc. Natl. Acad. Sci. USA 92, 9455^
9459.
[30] Wang, X.W. et al. (1995) Nature Genet. 10, 188^195.
[31] Mirzayans, R., Enns, L., Dietrich, K., Barley, R.D.C. and Pater-
son, M.C. (1996) Carcinogenesis 17, 691^698.
[32] Yokote, H. et al. (1998) Mutat. Res. 409, 147^162.
[33] Mummenbrauer, T., Janus, F., Muller, B., Wiesmuller, L., Dep-
pert, W. and Grosse, F. (1996) Cell 85, 1089^1099.
[34] Janus, F., Albrechtsen, N., Dornreiter, I., Wiesmuller, L.,
Grosse, F. and Deppert, W. (1999) Cell. Mol. Life Sci. 55, 12^27.
[35] Janus, F., Albrechtsen, N., Knippschild, U., Wiesmu«ller, L.,
Grosse, F. and Deppert, W. (1999) Mol. Cell. Biol. 19, 2155^
2168.
[36] Sturzbecher, H.-W., Donzelmann, B., Henning, W., Knippschild,
U. and Buchhop, S. (1996) EMBO J. 15, 1992^2002.
[37] Buchhop, S., Gibson, M.K., Wang, X.W., Wagner, P., Sturz-
becher, H.-W. and Harris, C.C. (1997) Nucleic Acid Res. 25,
3868^3874.
[38] Wang, X.W. et al. (1996) Genes Dev. 10, 1219^1232.
[39] Bakalkin, G. et al. (1995) Nucleic Acids Res. 23, 362^369.
[40] Bakalkin, G. et al. (1994) Proc. Natl. Acad. Sci. USA 91, 413^
417.
[41] Brain, R. and Jenkins, J.R. (1994) Oncogene 9, 1775^1780.
[42] Friedberg, E.C., Walker, G.C. and Siede, W. (1995) ASM Press,
Washington, DC.
[43] Sancar, A. (1996) Annu. Rev. Biochem. 65, 43^81.
[44] Aboussekhra, A. and Wood, R.D. (1994) Curr. Opin. Genet.
Dev. 4, 212^220.
[45] Seeberg, E., Eide, L. and Bjoras, M. (1995) Trends Biochem. Sci.
20, 391^397.
[46] Lindahl, T. (1993) Nature 362, 709^715.
[47] Michalovitz, D., Halevy, O. and Oren, M. (1990) Cell 62, 671^
680.
[48] Peled, A., Zipori, D. and Rotter, V. (1996) Cancer Res. 56, 2148^
2156.
[49] Zhang, W., Guo, X.Y., Hu, G.Y., Liu, W.B., Shay, J.W. and
Deisseroth, A.B. (1994) EMBO J. 13, 2535^2544.
[50] Yee, J.K., Friedmann, T. and Burns, J.C. (1994) Methods Cell
Biol. 43, 99^112.
[51] Dignam, J.D., Lebovitz, R.M. and Roeder, R.G. (1983) Nucleic
Acids Res. 11, 1474^1489.
[52] Wolkowicz, R., Elkind, N.B., Ronen, D. and Rotter, V. (1995)
Oncogene 10, 1167^1174.
[53] Harlow, E., Crawford, L.V., Pim, D.C. and Williamson, N.M.
(1981) J. Virol. 39, 861^869.
[54] Wang, Z., Svejstrup, J.Q., Feaver, W.J., Wu, X., Kornberg, R.D.
and Friedberg, E.C. (1994) Nature 368, 74^76.
[55] Frosina, G. et al. (1996) J. Biol. Chem. 271, 9573^9578.
[56] Burgers, P.M.J., Kornberg, A. and Sakakibara, Y. (1981) Proc.
Natl. Acad. Sci. USA 78, 5391^5395.
[57] Hainaut, P., Butcher, S. and Milner, J. (1995) Br. J. Cancer 71,
227^231.
[58] Ray, S., Anderson, M.E., Loeber, G., McVey, D. and Tegtmeyer,
P. (1992) J. Virol. 66, 6509^6516.
[59] Takeda, N., Miyamura, K., Takegami, T. and Yamazaki, S.
(1988) Virus Genes 2, 347^355.
[60] Wang, Z., Wu, X. and Friedberg, E.C. (1993) Mol. Cell. Biol. 13,
1051^1058.
[61] Miller, M.R. and Chinault, D.N. (1982) J. Biol. Chem. 257, 46^
49.
[62] Bargonetti, J., Friedman, P.N., Kern, S.E., Vogelstein, B. and
Prives, C. (1991) Cell 65, 1083^1901.
[63] El-Deiry, W., Kern, S.E., Pietenpol, J.A., Kinzler, K.W. and
Vogelstein, B. (1992) Nature Genet. 1, 45^49.
[64] Li, G. and Ho, V.C. (1998) Br. J. Dermatol. 139, 3^10.
[65] Gottlieb, T.M. and Oren, M. (1999) Semin. Cancer Biol. 8, 359^
368.
[66] Miyashita, T. and Reed, J.C. (1995) Cell 80, 293^299.
[67] Reinke, V. and Lozano, G. (1997) Oncogene 15, 1527^1534.
[68] Owen-Schaub, L.B. et al. (1995) Mol. Cell. Biol. 15, 3032^3040.
[69] Muller, M. et al. (1998) J. Exp. Med. 188, 2033^2045.
FEBS 21967 4-5-99
H. O¡er et al./FEBS Letters 450 (1999) 197^204 203
[70] Bennet, M., Macdonald, K., Chan, S.-W., Luzio, J.P., Simari, R.
and Weissberg, P. (1998) Science 282, 290^293.
[71] Gottlieb, E., Lindner, S. and Oren, M. (1996) Cell Growth Dif-
fer. 7, 301^310.
[72] Smith, M.L., Chen, I.T., Zhan, Q., O’Connor, P.M. and Fornace
Jr., A.J. (1995) Oncogene 10, 1053^1059.
[73] Grombacher, T., Eichhorn, U. and Kaina, B. (1998) Oncogene
17, 845^851.
[74] Banin, S. et al. (1998) Science 281, 1674^1677.
[75] Canman, C.E. et al. (1998) Science 281, 1677^1679.
[76] Siliciano, J.D., Canman, C.E., Taya, Y., Sakaguchi, K., Appella,
E. and Kastan, M.B. (1997) Genes Dev. 11, 3471^3481.
[77] Li, R. et al. (1998) Oncogene 16, 3269^3277.
[78] Hupp, T.R. and Lane, D.P. (1994) Curr. Biol. 4, 865^875.
[79] Halazonetis, T.D. and Kandil, A.N. (1993) EMBO J. 12, 1021^
1028.
FEBS 21967 4-5-99
H. O¡er et al./FEBS Letters 450 (1999) 197^204204
